Lei K J, Shelly L L, Pan C J, Sidbury J B, Chou J Y
Human Genetics Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.
Science. 1993 Oct 22;262(5133):580-3. doi: 10.1126/science.8211187.
Glycogen storage disease (GSD) type 1a is caused by the deficiency of D-glucose-6-phosphatase (G6Pase), the key enzyme in glucose homeostasis. Despite both a high incidence and morbidity, the molecular mechanisms underlying this deficiency have eluded characterization. In the present study, the molecular and biochemical characterization of the human G6Pase complementary DNA, its gene, and the expressed protein, which is indistinguishable from human microsomal G6Pase, are reported. Several mutations in the G6Pase gene of affected individuals that completely inactivate the enzyme have been identified. These results establish the molecular basis of this disease and open the way for future gene therapy.
1a型糖原贮积病(GSD)是由葡萄糖稳态的关键酶D-葡萄糖-6-磷酸酶(G6Pase)缺乏引起的。尽管发病率和患病率都很高,但这种缺乏背后的分子机制仍未得到明确表征。在本研究中,报告了人类G6Pase互补DNA、其基因以及表达的蛋白质(与人类微粒体G6Pase无法区分)的分子和生化特征。已在受影响个体的G6Pase基因中鉴定出几个完全使该酶失活的突变。这些结果确立了这种疾病的分子基础,并为未来的基因治疗开辟了道路。